Mongersen looks like being a $710m flop
Biotech has been in talks with US and EU regulators
This week’s news
Novo hopes for blockbuster sales from semaglutide
Ocrevus shines as biosimilars bite in Europe
Cancer cell therapy approved for aggressive blood cancer
Opdivo performed better than BMS’ Yervoy in clinical trial.
Firm was in talks with Crossover Health and approached primary care provider One Medical Group.
Federal court throws out patents on Restasis
Experimental device requires no user input at all.
AZ also unveils promising results from early-stage lung cancer combination
iSTEP integrates mobile technology, ‘smart’ blister packs of pills and electronic labelling.
New use could give J&J drug edge over Pfizer’s rival